Key Developments: Tongrentang Medical Care (02667) is offering 108 million H shares for global subscription from June 26 to July 2.

Keytop Parking (02272) reported its Hong Kong public offering was oversubscribed by approximately 2,115 times, with the international offering oversubscribed 5.56 times.

WENGE AI (01956) reported its Hong Kong public offering was oversubscribed by approximately 5,967 times, with net proceeds from the global offering amounting to about HK$827 million.

Shengbang Co., Ltd. (03661) reported its Hong Kong public offering was oversubscribed by approximately 252 times, with the international offering oversubscribed 23.5 times.

Lingyi iTech (Guangdong) Company (01688) reported its Hong Kong public offering was oversubscribed by approximately 96 times, with net proceeds from the global offering amounting to about HK$8.152 billion.

Sino IC Technology Co., Ltd. (09630) reported its Hong Kong public offering was oversubscribed by approximately 1,007 times.

MERDEKAGOLD-DRS (06228) reported its Hong Kong public offering was oversubscribed 4.42 times.

Hengrui Medicine (01276) announced its adebrelimab injection has received approval for an additional perioperative indication for non-small cell lung cancer (NSCLC).

CSTONE PHARMA-B (02616) has entered into an exclusive commercialization agreement with Arrotex for sugemalimab in Australia and New Zealand.

LBL Limited (09887) announced that Oblenio has completed an oversubscribed US$62 million Series B financing to accelerate the clinical development of LBL-051.



Financial Performance

BOSIDENG (03998) announced its annual results, with profit attributable to shareholders increasing by 13.7% year-on-year to approximately RMB 39.94 billion. A final dividend of HK 25 cents per share was declared.

Jinjing New Energy (01783) reported that revenue for the 2026 fiscal year increased by approximately 183.1% year-on-year. Profit attributable to owners was approximately HK$60.94 million, representing a turnaround from a loss to a profit compared to the previous year.

Luk Fook Holdings (International) Limited (00590) released its annual results, with profit attributable to shareholders reaching HK$2.046 billion, an increase of 86% year-on-year.

Johnson Holdings (01955) released its annual results, with revenue of HK$3.378 billion, an increase of 83.96% year-on-year.

MIGAO Group (09879) released its annual results, with profit attributable to shareholders reaching RMB 373 million, an increase of 21.47% year-on-year.